Long term efficacy is typically measured using survival rates, which include overall survival (OS) and progression-free survival (PFS). Overall survival refers to the percentage of patients who are still alive after a certain period post-treatment, while progression-free survival measures the length of time during and after treatment that a patient lives with the disease without it getting worse. Other metrics include disease-free survival (DFS) and quality of life (QoL) assessments.
